EUVIMEDEUVIMED entdecken
Crossref

L26/P-732 A family-building perspective in IVF: the contribution of each additional oocyte to cumulative live birth rate

E. Pittana, P. Petrone, A. Ruffa, F. Battista, F. Innocenti, M. Taggi, V. Morgante, C. Argento, S. Colamaria, M. Giuliani, S. Ferrero, I. Mappa und 3 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.1059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von E. Pittana und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Which is the contribution of each additional oocyte collected, regardless of the number of retrievals conducted, to the chance of 1 or 2 live-births (LBs)? Summary answer Each additional oocyte contributes to a 5.4%-increase in the odds of 1 LB and to a 6.5%-increase in the odds of 2 LBs. What is known already Maternal age, ovarian reserve, and male factor evaluation are among the strongest predictors for realizing the patient’s family plan. Tailoring ovarian stimulation strategies, adopting both conventional and unconventional protocols, aims to fully exploit the ovarian reserve by maximizing oocyte yield. In this context, every single oocyte plays a crucial role, as retrieving an adequate number of oocytes not only increases the likelihood of achieving one LB but also expands the potential for multiple births, thereby aligning treatment with the broader goal of supporting a comprehensive family-building plan and optimizing long-term reproductive outcomes. Study design, size, duration Retrospective analysis of 6507 couples undergoing ≤6 IVF attempts within 3 years between 2010 and 2020 at a private clinic. Endpoints included: number of metaphase-II (MII) oocytes required to achieve a first and a second LB within 3 years. The couples were clustered according to the total number of MII-oocytes retrieved (1–2, 3–4, 5–7, 8–12, 13–19, ≥20) and further stratified by maternal age (<35yr; 35-37yr; 38-39yr; 40-41yr; ≥42yr). Participants/materials, setting, methods Median maternal age was 38yr and median AMH 1.6ng/ml; 19% of couples presented severe male factor (SMF) infertility defined as oligoasthenoteratozoospermia or azoospermia. All patients underwent conventional-stimulation or DuoStim, ICSI, culture to day3/5-7, and fresh/vitrified-warmed untested/euploid embryo transfer. Regression analyses were conducted to outline associations with all study variables (either categoric, continuous or categorized as described previously) and the study endpoints. Main results and the role of chance Significant associations were observed between larger numbers of MII-oocytes retrieved and the chance of achieving ≥1 LB within 3 years across all maternal age groups (<38yr: 24% to 70%, 38-39yr: 15% to 55%, ≥40yr: 3%/5% to 30%; p < 0.001). Overall, each additional MII-oocyte retrieved was associated with a 5.4%-increase in the odds of 1 LB (OR:1.054,95%CI:1.046–1.062). When stratified by maternal age, the relative increase in odds was around 5% in women ≤42 years and 9.5% in women 43-44 years. Similarly, significant associations were observed also between larger numbers of MII-oocytes retrieved and the chance of achieving two LB within 3 years across all maternal age groups (<35yr: 3% to 29%, 35-37yr: 1% to 20%, 38-39yr: 0.5% to 15%,≥40yr: 0% to 4%; p < 0.001). Overall, each additional MII-oocyte retrieved was associated with a 6.5%-increase in the odds of 2 LBs (OR:1.065,95%CI:1.055–1.076), rather comparable across ranges of maternal age. Limitations, reasons for caution Retrospective study across 11 years. Indeed, the year at the first attempt was used to adjust all regressions. The MII-oocytes’ clusters were defined based on the distribution in our study population. The reduced sample size in patients with 2 LBs older than 38yr limited this secondary endpoint. Wider implications of the findings Effective reproductive planning requires time-sensitive strategies to optimize each stimulation cycle. Comprehensive counselling should address risks and benefits throughout IVF: reducing the chance of having no child while increasing the possibility of more than one. Multicycle approaches and oocyte accumulation protocols represent valuable strategies to support broader family-building goals Trial registration number No

Zitieren

APA

Pittana, E., Petrone, P., Ruffa, A., Battista, F., Innocenti, F., Taggi, M., Morgante, V., Argento, C., Colamaria, S., Giuliani, M., Ferrero, S., Mappa, I., Rienzi, L., Cimadomo, D., & Vaiarelli, A. (2026). L26/P-732 A family-building perspective in IVF: the contribution of each additional oocyte to cumulative live birth rate. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.1059

Vancouver

Pittana E, Petrone P, Ruffa A, Battista F, Innocenti F, Taggi M, et al. L26/P-732 A family-building perspective in IVF: the contribution of each additional oocyte to cumulative live birth rate. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.1059

BibTeX
@article{Pittana2026,
  author = {Pittana, E. and Petrone, P. and Ruffa, A. and Battista, F. and Innocenti, F. and Taggi, M. and Morgante, V. and Argento, C. and Colamaria, S. and Giuliani, M. and Ferrero, S. and Mappa, I. and Rienzi, L. and Cimadomo, D. and Vaiarelli, A.},
  title = {L26/P-732 A family-building perspective in IVF: the contribution of each additional oocyte to cumulative live birth rate},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.1059}
}
Kostenlos starten →